Clinical Trial

Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.
Trial Details
NCT Number NCT07664956
Lead Sponsor Christiana Care Health Services
Conditions Minimally Invasive Surgical Procedures, Abnormal Uterine Bleeding, Unspecified, Adenomyosis of Uterus, Fibroid Uterus, Chronic Pelvic Pain, Endometriosis, Menorrhagia, Endometritis +1 more
Enrollment 36 participants
Start Date 2026-07-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-24